Introduction

The Fatigue Severity Scale (FSS-16) is a self-report psychometric instrument designed to assess the severity of fatigue and its impact on everyday functioning. It evaluates how fatigue influences motivation, physical activity, work performance, family responsibilities, and social participation. The scale was originally developed by Krupp et al. (1989) to assess fatigue severity in individuals with neurological and chronic medical conditions and has since become one of the most widely used instruments for measuring fatigue-related impairment.

Description

The FSS-16 consists of 16 items assessing different dimensions of fatigue, including:

  • Physical fatigue.
  • Mental exhaustion.
  • Reduced motivation.
  • Difficulties with physical activities.
  • Interference with occupational functioning.
  • Impact on family and social life.
  • Limitations in daily activities.

Items are rated using a Likert-type response scale, where higher scores indicate greater fatigue severity and increased functional impairment.

Purpose

The FSS-16 is designed to:

  • Assess the severity and consequences of fatigue.
  • Evaluate the impact of fatigue on quality of life.
  • Differentiate fatigue-related impairment from other psychological symptoms.
  • Monitor changes following medical, psychological, or rehabilitation interventions.
  • Support research on chronic fatigue and health-related functioning.

Administration

The questionnaire is self-administered and requires only a few minutes to complete. It is suitable for adults and can be used in clinical, rehabilitation, occupational, and research settings. The instrument has been applied extensively in populations with multiple sclerosis, systemic lupus erythematosus, fibromyalgia, chronic fatigue conditions, neurological disorders, and other chronic illnesses.

Scoring

Each item is scored according to the selected Likert response. Individual item scores are summed or averaged to produce an overall fatigue severity score.

Higher scores indicate:

  • Greater fatigue intensity.
  • More significant interference with daily activities.
  • Reduced functional capacity.
  • Greater impact on social and occupational roles.

Lower scores indicate lower levels of fatigue and better functional ability.

Interpretation

High FSS-16 scores suggest clinically meaningful fatigue that may interfere with physical functioning, productivity, social participation, and overall quality of life. Elevated fatigue levels are frequently observed in chronic neurological and medical conditions.

The scale focuses on subjective fatigue severity and its functional consequences, rather than objective physical performance. Therefore, results should be interpreted together with clinical assessment and complementary measures of health status.

Statistical Analysis

Psychometric evaluation of the FSS-16 commonly includes:

  • Descriptive statistics.
  • Internal consistency reliability (Cronbach’s alpha).
  • Test–retest reliability.
  • Item-total correlations.
  • Exploratory Factor Analysis (EFA).
  • Confirmatory Factor Analysis (CFA).
  • Convergent and discriminant validity.
  • Correlation and regression analyses.
  • Group comparisons (t-test, ANOVA, ANCOVA).
  • Responsiveness analysis for treatment outcomes.

Research has demonstrated strong internal consistency, good validity, and sensitivity to differences between healthy individuals and patients experiencing chronic fatigue-related conditions.

Applications

The FSS-16 is widely used in:

  • Neurology.
  • Rheumatology.
  • Rehabilitation medicine.
  • Health psychology.
  • Chronic disease management.
  • Occupational health.
  • Quality-of-life research.
  • Clinical intervention studies.

Advantages

  • Brief and easy to administer.
  • Evaluates both fatigue severity and functional impact.
  • Suitable for diverse clinical populations.
  • Supported by extensive international research.
  • Useful for monitoring changes over time.

Limitations

As a self-report measure, the FSS-16 may be influenced by mood, personal perception of fatigue, current health status, and response bias. It assesses perceived fatigue rather than objective energy expenditure or physical performance. Interpretation should therefore include additional clinical and functional assessments.

References

Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The Fatigue Severity Scale: Application to Patients with Multiple Sclerosis and Systemic Lupus Erythematosus. Archives of Neurology, 46(10), 1121–1123.

Learmonth, Y. C., Dlugonski, D., Pilutti, L. A., Sandroff, B. M., & Motl, R. W. (2013). Psychometric Properties of the Fatigue Severity Scale in Multiple Sclerosis.

Neuberger, G. B. (2003). Measures of Fatigue: The Fatigue Severity Scale and Related Instruments.

Introduction

The Fatigue Severity Scale (FSS-16) is a self-report psychometric instrument designed to evaluate the severity of fatigue and its impact on daily functioning. It measures how fatigue affects motivation, physical activity, work performance, family responsibilities, and social participation. The scale is widely used in clinical medicine, rehabilitation, neurology, and health psychology to assess fatigue associated with chronic medical and neurological conditions, as well as in general population research.

Description

The FSS-16 consists of 16 items assessing multiple aspects of fatigue, including:

  • Physical fatigue.
  • Mental exhaustion.
  • Reduced motivation.
  • Interference with daily activities.
  • Impact on occupational performance.
  • Effects on family and social life.
  • Functional limitations caused by fatigue.

Items are typically rated using a Likert-type response scale, with higher scores indicating greater fatigue severity and functional impairment.

Purpose

The FSS-16 is designed to:

  • Assess the severity of fatigue.
  • Differentiate clinically significant fatigue from normal tiredness.
  • Evaluate the functional consequences of fatigue.
  • Monitor changes following medical or psychological treatment.
  • Support research on fatigue across a wide range of chronic health conditions.

Administration

The questionnaire is self-administered and generally requires 5–10 minutes to complete. It is appropriate for adults in clinical, rehabilitation, occupational, and research settings. The instrument is commonly administered to individuals with neurological disorders, autoimmune diseases, chronic illnesses, cancer, and other conditions where fatigue is a prominent symptom.

Scoring

Each item is scored according to the selected Likert response, and responses are summed or averaged to produce an overall fatigue score. Higher scores indicate greater fatigue severity and a stronger negative impact on everyday functioning, whereas lower scores reflect minimal fatigue-related impairment.

Interpretation

Higher FSS-16 scores indicate clinically meaningful fatigue that may substantially interfere with physical functioning, work productivity, cognitive performance, and quality of life. Elevated scores are frequently associated with chronic neurological disorders, autoimmune diseases, chronic fatigue conditions, depression, and other long-term medical illnesses. Lower scores suggest relatively preserved energy levels and better functional capacity.

Statistical Analysis

Psychometric evaluation of the FSS-16 commonly includes:

  • Descriptive statistics.
  • Internal consistency (Cronbach’s alpha).
  • Test–retest reliability.
  • Exploratory and Confirmatory Factor Analysis (EFA/CFA).
  • Item-total correlations.
  • Convergent and discriminant validity.
  • Correlation and regression analyses.
  • Group comparisons (t-test, ANOVA, ANCOVA).
  • Receiver Operating Characteristic (ROC) analysis when evaluating diagnostic accuracy.

Research has demonstrated that fatigue severity measures based on the FSS framework possess excellent internal consistency and good construct validity, supporting their use in both clinical practice and scientific research.

Applications

The FSS-16 is widely used in:

  • Neurology.
  • Health psychology.
  • Rehabilitation medicine.
  • Rheumatology.
  • Oncology.
  • Primary healthcare.
  • Chronic disease management.
  • Quality-of-life research.

Advantages

  • Brief and easy to administer.
  • Comprehensive assessment of fatigue severity and its functional consequences.
  • Suitable for a wide variety of clinical populations.
  • Sensitive to treatment-related changes.
  • Appropriate for both clinical practice and epidemiological research.

Limitations

As a self-report instrument, the FSS-16 may be influenced by mood, motivation, response bias, and cultural perceptions of fatigue. It measures subjective fatigue severity rather than objective physical performance and should therefore be interpreted alongside clinical evaluation and complementary health assessments.

References

Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The Fatigue Severity Scale: Application to Patients with Multiple Sclerosis and Systemic Lupus Erythematosus.

Learmonth, Y. C., Dlugonski, D., Pilutti, L. A., Sandroff, B. M., & Motl, R. W. (2013). Psychometric Properties of the Fatigue Severity Scale in Multiple Sclerosis.

Lerdal, A., et al. (2010). Psychometric Properties of the Fatigue Severity Scale: Rasch Analyses in Multiple Sclerosis.

Neuberger, G. B. (2003). Measures of Fatigue: The Fatigue Severity Scale and Related Instruments.

Scale Analysis

The Fatigue Severity Scale (FSS-16) is a self-administered questionnaire designed to assess the severity of fatigue in various situations over a specific period. Originally developed by Krupp and colleagues, the scale aims to quantify how fatigue impacts individuals’ daily lives.

Purpose

The primary purpose of the FSS is to differentiate fatigue from clinical depression, as both conditions can share overlapping symptoms.

Scoring

Each item on the scale is rated from 1 to 7, where 1 indicates strong disagreement and 7 indicates strong agreement. The final score is calculated as the average of the 9 items. This unidimensional scale consists of 9 questions that address the most fundamental symptoms of fatigue and its impact on daily functioning.

Statistical Analysis

The FSS yields a composite score derived from the statistical processing of the responses, calculated as the mean value of the 9 items. Respondents rate their agreement using a Likert-type scale, where 1 = strongly disagree, 7 = strongly agree, and 4 represents a neutral midpoint. The neutral point (4) is the upper limit for indicating the absence of clinically significant fatigue.

Validity and Reliability

The FSS is the most widely used fatigue assessment tool. Its reliability and validity have been confirmed in numerous studies across English-speaking and non-English-speaking populations with various systemic and neurological conditions.

References

Schwartz, J. E., Jandorf, L., & Krupp, L. B. (1993). The measurement of fatigue: a new instrument. Journal of Psychosomatic Research, 37(7), 753–762.